Verition Fund Management
AVXL icon

Verition Fund Management’s Anavex Life Sciences AVXL Stock Holding History

Verition Fund Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,859
Closed -$613K – 3502
2025
Q3 		$613K Buy
68,859
+36,039
+110% +$366K ﹤0.01% 2902
2025
Q2 		$303K Sell
32,820
-40,989
-56% -$350K ﹤0.01% 3197
2025
Q1 		$633K Buy
73,809
+37,142
+101% +$351K ﹤0.01% 2419
2024
Q4 		$394K Buy
+36,667
New +$282K ﹤0.01% 2622
2016
Q2 		– Sell
-16,478
Closed -$81K – 871
2016
Q1 		$81K Buy
+16,478
New +$72.5K 0.01% 669

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Verition Fund Management's AVXL Position: Q4 2025 in Review

Verition Fund Management sold out of Anavex Life Sciences (AVXL) in Q4 2025, closing a stake of 68,859 shares — an estimated $613K sold.

Verition Fund Management first reported a position in AVXL in Q1 2016 and held it in 5 quarters. The position peaked at $633K in Q1 2025. 183 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

  • Verition Fund Management reported no remaining Anavex Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 68,859 Anavex Life Sciences shares in Q4 2025, an estimated $613K.
  • Verition Fund Management first reported a position in Anavex Life Sciences in Q1 2016 and held it in 5 quarters.
  • Verition Fund Management's Anavex Life Sciences position peaked at $633K in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.